Your browser doesn't support javascript.
loading
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
Ooki, Akira; Morita, Satoshi; Tsuji, Akihito; Iwamoto, Shigeyoshi; Hara, Hiroki; Tanioka, Hiroaki; Satake, Hironaga; Kataoka, Masato; Kotaka, Masahito; Kagawa, Yoshinori; Nakamura, Masato; Shingai, Tatsushi; Ishikawa, Masashi; Miyake, Yasuhiro; Suto, Takeshi; Hashiguchi, Yojiro; Yabuno, Taichi; Ando, Masahiko; Sakamoto, Junichi; Yamaguchi, Kensei.
Affiliation
  • Ooki A; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. sp9y9tq9@piano.ocn.ne.jp.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University, Kyoto, Japan.
  • Tsuji A; Department of Medical Oncology, Kagawa University, Kita, Japan.
  • Iwamoto S; Department of Surgery, Kansai Medical University Kouri Hospital, Neyagawa, Japan.
  • Hara H; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Tanioka H; Department of Clinical Oncology, Kawasaki Medical School, Kurashiki, Japan.
  • Satake H; Cancer Treatment Center, Kansai Medical University Hospital, Osaka, Japan.
  • Kataoka M; Department of Surgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Kotaka M; Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan.
  • Kagawa Y; Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan.
  • Nakamura M; Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan.
  • Shingai T; Department of Surgery, Osaka Saiseikai Senri Hospital, Suita, Japan.
  • Ishikawa M; Department of Surgery, Shikoku Central Hospital, Shikokuchuo, Japan.
  • Miyake Y; Department of Surgery, Osaka Minato Central Hospital, Osaka, Japan.
  • Suto T; Department of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Hashiguchi Y; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
  • Yabuno T; Department of Surgery, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
  • Ando M; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan.
  • Yamaguchi K; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
BMC Cancer ; 22(1): 711, 2022 Jun 28.
Article in En | MEDLINE | ID: mdl-35765021
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Colorectal Neoplasms / Cetuximab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Colorectal Neoplasms / Cetuximab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Japan